Insulin/IGF resistance in AD brain leads to decreased phosphoinositol-3-kinase (PI3K)/Akt [23,24] and Wnt/β-catenin signaling [25], as well as increased activation of glycogen synthase kinase 3β (GSK-3β). Here, AKT1 is linked to Alzheimer disease.